Found 24 matching trials
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer PHASE2 This phase II trial evaluates whether early switching from modified fluorou...
Show More Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer PHASE2 Abbreviated Title: Neoadjuvant FOLFIRINOX combined with Pembrolizumab follo...
Show More Location
Baylor College of Medicine
Learn More & Join Trial
A Trial Using Transcriptomic Signatures to Personalize Neoadjuvant Chemotherapy (NAC) for Patients With Resectable Borderline Pancreatic Adenocarcinoma (PDAC) NA Pancreatic cancer exhibits significant heterogeneity, which poses a major c...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoadjuvant Modified FOLFIRINOX and Stereotactic Body Radiation Therapy in Borderline Resectable Pancreatic Adenocarcinoma PHASE2 Surgical resection is the only potentially curative treatment for patients ...
Show More Location
Smilow Cancer Hospital
Learn More & Join Trial
Pancreatic Cancer With Elevated Serum CA125 Were Compared With Those Who Did Not Receive Neoadjuvant Chemotherapy. PHASE3 The main purpose of
* To observe the overall survival of patients with res...
Show More Location
Multiple Locations
Learn More & Join Trial
Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer PHASE2 This phase II trial studies how well combination chemotherapy before and af...
Show More Location
Smilow Cancer Hospital at Fairfield
Learn More & Join Trial
Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial) PHASE1 This is a phase 1b prospective, single arm, open-label trial determining th...
Show More Location
Chao Family Comprehensive Cancer Center, University
Learn More & Join Trial
A Phase 2 Trial of Neoadjuvant Modified FOLFIRINOX Chemotherapy for Resectable Pancreatic Adenocarcinoma PHASE2 Within the next decade, pancreatic ductal adenocarcinoma (PDAC) is expected...
Show More Location
Division of Medical Oncology, Yonsei Cancer Center, Yonsei Univ. College of Medicine, Korea
Learn More & Join Trial
Evaluation Contact X-ray Brachytherapy for Rectal Preservation in Intermediate Substage Rectal Adenocarcinoma PHASE3 Indication : Adult patients with intermediate low or mid rectal adenocarcin...
Show More Location
Institut Sainte Catherine
Learn More & Join Trial
Neoadjuvant Treatment vs Upfront Surgery for Left-Sided Pancreatic Cancer PHASE3 Pancreatic cancer is one of the most treatment resistant malignancies, ofte...
Show More Location
Helsinki University Central Hospital
Learn More & Join Trial